SBFM

SBFM

USD

Sunshine Biopharma Inc. Common Stock

$1.510+0.000 (0.000%)

السعر في الوقت الحقيقي

Healthcare
Drug Manufacturers - Specialty & Generic
الولايات المتحدة

مخطط الأسعار

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$1.510

الأعلى

$1.570

الأدنى

$1.450

الحجم

0.01M

أساسيات الشركة

القيمة السوقية

5.6M

الصناعة

Drug Manufacturers - Specialty & Generic

البلد

United States

إحصاءات التداول

متوسط الحجم

1.43M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $1.169الحالي $1.510الأعلى $23.2

أخبار ذات صلة

AccessWire

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology

عرض المزيد
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
AccessWire

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

عرض المزيد
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
AccessWire

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

عرض المزيد
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
AccessWire

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

عرض المزيد
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.